Dexdomitor
dexmedetomidine
Table of contents
Overview
This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.
This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).
Authorisation details
Product details | |
---|---|
Name |
Dexdomitor
|
Agency product number |
EMEA/V/C/000070
|
Active substance |
Dexmedetomidine hydrochloride
|
International non-proprietary name (INN) or common name |
dexmedetomidine
|
Species |
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QN05CM18
|
Publication details | |
---|---|
Marketing-authorisation holder |
Orion Corporation
|
Revision |
20
|
Date of issue of marketing authorisation valid throughout the European Union |
30/08/2002
|
Contact address |
Orionintie 1 |
Product information
19/03/2021 Dexdomitor - EMEA/V/C/000070 - IAIN/0043
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Psycholeptics
Therapeutic indication
Noninvasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats.
Premedication in cats before induction and maintenance of general anaesthesia with ketamine.
Deep sedation and analgesia in dogs in concomitant use with butorphanol for medical and minor surgical procedures.
Premedication in dogs before induction and maintenance of general anaesthesia.